Tweets help health experts track opioid misuse

Monitoring use of social media platforms like Twitter can help researchers detecting misuse of opioid drugs in certain areas, according to a study published in the Journal of Medical Toxicology.

Social media has become a place where users express themselves and discuss what is going on in their lives, making platforms like Twitter a perfect population health tool. In this study, researchers used Twitter to examine data on opioid abuse and compared data with a federal survey to outline the usefulness of social medical tools.

Led by Michael Chary, with the Department of Emergency Medicine of New York Presbyterian\Queens Hospital, researchers collected tweets using keywords related to opioid misuse. The software retrieved 3,611,528 relevant tweets from 2012 to 2014. The study then compared the Twitter data to geographical data collected from the 2013-2015 National Surveys on Drug Usage and Health (NSDUH).

Results showed the misuse of prescription opioid data found on Twitter strongly correlated with state information from the NSDUH. Correlation was strongest in individuals between 18 and 25 years old.

"We found that our estimates agreed with national survey data, suggesting that social media can be a reliable additional source of epidemiological data regarding substance use," said Chary. "Traditional methods of gauging opioid misuse in an area rely on compiling reports from local emergency rooms and poison control call centers. Through social media we can observe a much larger fraction of the population, perhaps intervening before things reach the level of needing emergency medical care."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.